AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Sectors:
Analyst Ranking
Bottom 6%
#4881 out of 5179 analysts
Average Return
-3.94%
Win Rate
42%15 out of 36
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Definium Therapeutics IncDFTX | +130.82% | $7.43 | $17.15 | 2025-01-27 - 2026-01-21 | Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-20 - 2024-12-20 | Buy |
Forte Biosciences IncFBRX | +57.58% | $19.99 | $31.50 | 2025-11-24 - 2026-01-21 | Buy |
Mirum Pharmaceuticals IncMIRM | +55.53% | $59.97 | $93.27 | 2025-08-07 - 2026-01-21 | Buy |
Argenx SeARGX | +53.92% | $596.74 | $918.50 | 2024-11-20 - 2025-11-20 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dyne Therapeutics IncDYN | 1 | Buy | $36.00 | +105.71% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 4 | Buy | $94.00 | +0.78% | Maintains | a month ago |
Vera Therapeutics IncVERA | 1 | Buy | $97.00 | +111.93% | Maintains | a month ago |
Evommune IncEVMN | 1 | Buy | $40.00 | +112.20% | Initiates Coverage On | 2 months ago |
Forte Biosciences IncFBRX | 1 | Buy | $65.00 | +106.35% | Initiates Coverage On | 2 months ago |
Argenx SeARGX | 5 | Buy | $910.00 | +11.47% | Maintains | 3 months ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $14.00 | +821.05% | Maintains | 4 months ago |
Abbvie IncABBV | 5 | Buy | $222.00 | +2.71% | Maintains | 4 months ago |
Proqr Therapeutics NvPRQR | 1 | Buy | $5.00 | +204.88% | Initiates Coverage On | 9 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $23.00 | +34.11% | Initiates Coverage On | a year ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | N/A | Maintains | a year ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Krystal Biotech IncKRYS | 1 | Buy | $206.00 | N/A | Maintains | a year ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $10.00 | N/A | Maintains | 3 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.